 53 PM / Updated 9 minutes ago BRIEF-Avexis Announces Expanded Clinical Development Program For AVXS-101 In Spinal Muscular Atrophy Reuters Staff 
Jan 16 (Reuters) - Avexis Inc: 
* AVEXIS ANNOUNCES EXPANDED CLINICAL DEVELOPMENT PROGRAM FOR AVXS-101 IN SPINAL MUSCULAR ATROPHY 
* AVEXIS - TO EXPAND STUDY OF AVXS-101 INTO ADDITIONAL SMA POPULATIONS INCLUDING PRE-SYMPTOMATIC, OLDER PEDIATRIC TYPE 2 AND TYPE 3 SMA PATIENTS 
* AVEXIS INC - ‍PLANS TO INITIATE THREE STUDIES TO FURTHER EVALUATE AVXS-101, INCLUDING IN NEW SMA PATIENT POPULATIONS​ 
* AVEXIS INC - ‍EXPECTS TO INITIATE PIVOTAL TRIAL OF AVXS-101 IN SMA TYPE 1 IN EUROPE​ IN FIRST HALF OF 2018 Source text for Eikon: Further company coverage: